Reduction of cellular polyamine pools results in inhibition of cell proliferation and sometimes in induction of cell death. Reduction of cellular polyamine pools can be achieved by several strategies involving all the mechanisms of polyamine homoeostasis, i.e. biosynthesis, catabolism and transport across the cell membrane. In the present paper, we concentrate on results achieved using the polyamine analogue DENSPM (N 1 ,N 11 -diethylnorspermine) on different cell lines. We discuss polyamine levels in DENSPM-treated cells in relation to effects on cell cycle kinetics and induction of apoptosis. To really understand the role of polyamines in cell cycle regulation and apoptosis, we believe it is now time to go through the vast polyamine literature in a meta-analysis-based manner. This short review does not claim to be such a study, but it is our hope to stimulate such studies in the polyamine field. Such work is especially important from the viewpoint of introducing drugs that affect polyamine homoeostasis in the treatment of various diseases such as cancer.
Introduction
Complex networks of interacting molecules govern cell proliferation, cell differentiation and cell death. Normal life requires that these networks are more or less intact and it has been speculated that five to ten network aberrations can lead to the development of cancer. One group of players in these networks are the natural polyamines putrescine, spermidine and spermine [1] [2] [3] . It is well known that normal cell proliferation requires that the cell maintains a certain level of polyamines. Polyamine pool homoeostasis is carefully controlled by biosynthesis, catabolism and transport across the cell membrane. As polyamines have a critical role in cell proliferation, the polyamine metabolic pathway naturally represents a potential target for intervention in cancer [4] [5] [6] [7] [8] [9] . There are a number of strategies to reduce the polyamine pools. The initial strategy was to inhibit the biosynthetic enzymes. A second strategy was to use polyamine analogues which proved to be even more efficient in depleting the polyamine pools than the inhibitors of the biosynthetic enzymes. A third strategy is the use of inhibitors of polyamine transport. The efficient depletion of the natural polyamine pools by synthetic analogues is due to several mechanisms. First, the cell recognizes the analogues as polyamines, and they are efficiently taken up by the polyamine transport system. Thus polyamine analogues accumulate at high concentrations inside the cell. As high concentrations of polyamines are detrimental, polyamine biosynthesis is subsequently inhibited.
In addition, many analogues induce polyamine catabolism, as the perceived polyamine concentration in the cell is too high. However, only the natural polyamines are catabolized efficiently, leaving the cell with a high concentration of the polyamine analogue. Although the analogues can affect polyamine metabolism through their likeness to natural polyamines, they cannot take over the molecular functions of the polyamines in the cell. As a consequence of polyamine analogue-induced polyamine depletion, cell proliferation ceases and, in some cases, cell death has also been observed.
A number of studies with different analogues have been performed [4] [5] [6] 8, 9] . From these studies, it is apparent that each analogue has its own very specific mechanism of action involving the different effects on polyamine metabolism mentioned above. In addition, they can have other effects not directly related to polyamine metabolism. However, the analogues are often discussed as if they all had the same mechanism of action. To better understand the mechanism of action of polyamine analogues, we think it is time to discuss results from each analogue alone, which eventually should lead to a discussion of all analogues together. The present limited review will make an attempt to sum up data on the polyamine analogue DENSPM (N 1 ,N 11 -diethylnorspermine). We will concentrate on the effects of DENSPM on cell proliferation and apoptosis in cell lines in relation to the cellular polyamine levels.
DENSPM treatment efficiently depletes the polyamine pools. A major role in the degree of polyamine depletion achieved is related to the induction of the polyamine catabolic enzyme SSAT (spermidine/spermine N 1 -acetyltransferase) [10] . The present paper will not address the relationship between SSAT induction and polyamine pool depletion, but only the actual polyamine pools achieved after treatment with DENSPM. Also, we will only compare the actual polyamine pools in DENSPM-treated cells and not the degree of depletion in relation to control levels of polyamines. We think the actual pool size is more important than a comparison with control. In addition, we believe it is important to make comparisons on a per cell basis, as we believe that the function in a cell that is supported by polyamines is not dependent on total cellular protein content. Results from our own work with DENSPM will be presented and discussed in relation to other published data. Tables 1 and 2 show the polyamine pools in a normal-like breast epithelial (MCF-10A), breast cancer (MCF-7, SK-BR-3, HCC1937 and L56Br-C1) and neuroblastoma (SH-SY5Y and LA-N-1) cell lines treated with 10 µM DENSPM for 24 and 48 h respectively. The concentration of DENSPM chosen is mainly based on a mean achievable dose in vivo [5] . In addition, this is the most commonly used dose of DENSPM in experiments using cell lines. Tables 1 and 2 , it is obvious that treatment with 10 µM DENSPM for 24 and 48 h results in different polyamine pools in the studied cell lines. The numbers in parentheses are percentage of control for those interested in control values. The most efficient polyamine depletion was found in the L56Br-C1 cell line and the least efficient in SK-BR-3 and L-AN-1 cells.
Effect of DENSPM treatment on polyamine pools
The effect of DENSPM treatment has been extensively studied in MALME-3M and SK-MEL-28 human melanoma cell lines [11] [12] [13] [14] . In MALME-3M cells, putrescine, spermidine and spermine levels were 205, 60 and 285 pmol/ 10 6 cells respectively after 24 h of treatment with 10 µM DENSPM, and in SK-MEL-28 they were 70, 20 and 105 pmol/10 6 cells respectively [13] . The other three cited studies show similar values [11, 12, 14] .
In the two human bladder cancer cell lines T24 and J82, treatment with 10 µM DENSPM for 24 h, resulted in putrescine, spermidine and spermine values in the range 50-180, 120-480 and 90-280 pmol/10 6 cells respectively [15] . Very efficient polyamine pool depletion by treatment with 10 µM DENSPM was found in human non-small cell lung carcinoma NCI-H157 [16] where putrescine and spermidine were not detected after 24 h of treatment and the spermine pool was 0.58 nmol/mg of protein. In the same cell line, it was found that the polyamine pool size achieved after DENSPM treatment was dependent on the growth status of the cells [17] . Lower polyamine pools were found in more rapidly growing cells than in slow-growing cells. In human LNCaP, PC-3 and Du-145 prostate cancer cell lines, after treatment with 10 µM DENSPM for 24 h, putrescine, spermidine and spermine pools were between 2 and 4.6, 4.2 and 7.8 and 2.5 and 20.4 nmol/mg of protein respectively [18] . The effect of DENSPM on polyamine pools was investigated in Chinesehamster ovary cell lines, one of which was selected for resistance to DENSPM [19] . The polyamine pools were similar to those described above for the prostate cell lines. In another study using four human prostate cell lines (PC-3, TSU-pr1, Du-145, and JCA-1), treatment with 100 µM DENSPM for 48 h resulted in putrescine, spermidine and spermine pools of between 1 and 3 nmol/mg of protein [20] . Thus, despite the very high DENSPM concentration used in this study, polyamine levels were not much lower than in cells treated with 10 µM DENSPM. No information about polyamine pools in relation to cell number was found in these papers.
Altogether, these data show that DENSPM treatment results in different polyamine pool levels. As already mentioned above, an important factor contributing to the difference in polyamine pools is the activation of SSAT. However, in DENSPM-treated MCF-7 cells, there is no activation of SSAT (results not shown), thus the decrease in the polyamine pools must be due to inhibition of biosynthesis and also increased export of the natural polyamines. The variation in polyamine pools observed in DENSPM-treated cells is presumably caused by different genetic background pertaining to the entire regulation of the polyamine pools, including a number of factors that cannot be discussed in this context.
Effect of DENSPM treatment on polyamine pools in relation to inhibition of cell proliferation
It is undisputable that polyamine depletion causes inhibition of cell proliferation. An important question is to what levels do polyamines have to be reduced in order to achieve an effect on cell proliferation. An effect on cell proliferation is defined as a reduction in the rate of cell cycle progression. When cell proliferation is maximally affected, there is total block of cell cycle progression. A reduction in the rate of cell proliferation can be due to differential effects on the different cell cycle phases. From a cancer treatment point of view, a total block of cell proliferation is more favourable, although differential effects could be utilized in combination treatments with cell-cycle-phase-specific drugs. In normal cells, such a block should be reversible with minimal damage to the cells.
We have performed extensive studies on cell cycle kinetics using the DNA-bromodeoxyuridine flow cytometry method [21] in the normal-like cell line MCF-10A and in the breast cancer cell lines (Tables 1 and 2) . From these kinds of data, it is possible to speculate about levels of polyamines that are needed for various cell-cycle-related processes. It is also possible to speculate about the role of different polyamine levels in cell cycle regulation in different genetic backgrounds. Within the present paper, it is not possible to go through all the data in the Tables and we will discuss some examples only.
DENSPM treatment affected cell cycle kinetics the least in SK-BR-3 cells and this cell line also has the highest polyamine levels after 24 h of DENSPM treatment. At the observed polyamine levels, there was no block in the rate of G 1 /S transition or change in the length of the G 2 + M phase compared with control at either 24 or 48 h of treatment. Interestingly, in MCF-7 cells, the polyamine levels were similar to those in SK-BR-3 cells after 48 h of DENSPM treatment, and in MCF-7 cells, there was a G 1 /S block. It is highly likely that this difference is due to the presence of wild-type p53 in MCF-7 cells in contrast with the mutated p53 in SK-BR-3 cells. A similar phenomenon has been observed in melanoma cell lines, but has not been discussed in relation to polyamine levels [13] . Thus, in MCF-7 cells, the polyamine pools are presumably sufficient for G 1 /S transition, but other mechanisms overrule the polyamine pool sufficiency.
Another observation is the DENSPM-induced lengthening of the S-phase observed in all cell lines, even in SK-BR-3 cells. Thus normal S-phase progression appears to have higher polyamine pool requirements than progression through the other cell cycle phases, although the reason for this remains to be discussed.
Inhibition of cell proliferation was found in all studies mentioned above [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] , something which is not surprising in the light of the sensitivity of the S-phase to low polyamine pools. Tables 1 and 2 also show the induction of cell death in the seven cell lines that we have treated with DENSPM. Cell death was monitored by flow cytometry as the appearance of a sub-G 1 region in the DNA histogram [22] . A rapid induction of cell death was observed in L56Br-C1 cells where the polyamine pools were lowest. Of the cell lines mentioned above, rapid DENSPM-induced cell death was observed in the human non-small cell lung carcinoma cell line NCI-H157 [16] and in the human melanoma cell line SK-MEL-28 [13] . In these three cancer cell lines, polyamine pools were the lowest after DENSPM treatment. We believe that there is a narrow concentration level that determines whether cell death will be induced or not in a cancer cell. It has been shown that DENSPM-induced cell death is apoptotic involving the mitochondria [12, 14, 16, 23 ]. Whether or not this level of polyamines is overruled by other mechanisms has to be clarified. Presumably, other mechanisms will not permit the lowering of polyamines to a level that induces apoptosis in a healthy cell. It is also apparent from our data and from the data of others presented above [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] that the low levels of polyamines presumably required for the induction of apoptosis are not achieved by DENSPM treatment in all cancer cell lines. Thus, from a cancer treatment point of view in relation to induction of apoptosis, it is important to find biomarkers for sensitivity to DENSPM and for other polyamine analogues to avoid inefficient treatment.
Effect of DENSPM treatment on polyamine pools in relation to induction of apoptosis

DENSPM treatment and oxidative stress
Apoptosis-inducing effects of DENSPM have been related to the fact that H 2 O 2 is produced in the polyamine catabolic process [10, 24] . However, we think further studies are needed to investigate the role of H 2 O 2 in DENSPM-induced apoptosis in relation to the role of polyamine levels. This has been addressed in a study where primary mouse fetal fibroblasts were isolated from a transgenic mouse line with SSAT overexpression [25] . Transgenic fibroblasts were more sensitive to DENSPM-induced growth inhibition than non-transgenic fibroblasts. Spermidine pools were more rapidly depleted in the former than in the latter owing to the much higher SSAT activity. The growth inhibition was not diminished by co-treatment with an inhibitor of the H 2 O 2 -producing step, thus suggesting that growth inhibition was due to polyamine depletion itself as opposed to oxidative stress. We have a similar observation in the L56Br-C1 cell line (Figure 1 ) where co-treatment with an inhibitor of the H 2 O 2 -producing step did not significantly reduce the effect of DENSPM treatment in a cytotoxicity assay using AlamarBlue TM [26] . In this discussion, we do not wish to exclude or diminish the role of H 2 O 2 in DENSPM-induced apoptosis, but to point out that the role of the low polyamine pools itself should not be forgotten. We have proposed that spermine may prevent the release of cytochrome c from the mitochondria [27] , although there are other theories of the role of spermine in apoptosis [28, 29] .
Conclusion
Our limited 'meta-analysis' of experimental data obtained after treatment of cell lines with DENSPM shows that the actual polyamine pools achieved after DENSPM treatment may be more important to consider than the reduction in pool sizes compared with control. It may also be important to monitor polyamine pools more closely in relation to molecular and cellular events because there may be defined limiting levels of polyamines for different processes. It is clear that the S-phase is very sensitive to polyamine pool reduction and that reduction of polyamine pools below a certain level results in apoptosis in cancer cell lines.
